The global Sterile Injectable Contract Manufacturing Market is witnessing substantial growth as pharmaceutical and biotechnology companies increasingly rely on specialized manufacturing partners to meet rising demand for complex injectable therapies. According to Polaris Market Research, the market was valued at USD 15.96 billion in 2024 and is projected to reach USD 50.38 billion by 2034,...